RhumbLine Advisers’s Minerva Neurosciences NERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-5,219
| Closed | -$122K | – | 3069 |
|
|
2021
Q1 | $122K | Hold |
5,219
| – | – | ﹤0.01% | 2913 |
|
|
2020
Q4 | $98K | Buy |
5,219
+337
| +7% | +$6.33K | ﹤0.01% | 2969 |
|
|
2020
Q3 | $124K | Sell |
4,882
-564
| -10% | -$14.3K | ﹤0.01% | 2827 |
|
|
2020
Q2 | $157K | Buy |
5,446
+238
| +5% | +$6.86K | ﹤0.01% | 2851 |
|
|
2020
Q1 | $251K | Hold |
5,208
| – | – | ﹤0.01% | 2482 |
|
|
2019
Q4 | $296K | Buy |
5,208
+130
| +3% | +$7.39K | ﹤0.01% | 2594 |
|
|
2019
Q3 | $315K | Buy |
5,078
+45
| +0.9% | +$2.79K | ﹤0.01% | 2556 |
|
|
2019
Q2 | $227K | Buy |
5,033
+30
| +0.6% | +$1.35K | ﹤0.01% | 2739 |
|
|
2019
Q1 | $315K | Sell |
5,003
-111
| -2% | -$6.99K | ﹤0.01% | 2523 |
|
|
2018
Q4 | $276K | Buy |
5,114
+1,667
| +48% | +$90K | ﹤0.01% | 2581 |
|
|
2018
Q3 | $346K | Sell |
3,447
-210
| -6% | -$21.1K | ﹤0.01% | 2448 |
|
|
2018
Q2 | $241K | Buy |
3,657
+760
| +26% | +$50.1K | ﹤0.01% | 2646 |
|
|
2018
Q1 | $145K | Sell |
2,897
-21
| -0.7% | -$1.05K | ﹤0.01% | 2677 |
|
|
2017
Q4 | $141K | Sell |
2,918
-554
| -16% | -$26.8K | ﹤0.01% | 2723 |
|
|
2017
Q3 | $211K | Buy |
3,472
+87
| +3% | +$5.29K | ﹤0.01% | 2708 |
|
|
2017
Q2 | $240K | Buy |
3,385
+893
| +36% | +$63.3K | ﹤0.01% | 2668 |
|
|
2017
Q1 | $161K | Buy |
2,492
+99
| +4% | +$6.4K | ﹤0.01% | 2707 |
|
|
2016
Q4 | $225K | Buy |
2,393
+241
| +11% | +$22.7K | ﹤0.01% | 2628 |
|
|
2016
Q3 | $243K | Buy |
2,152
+197
| +10% | +$22.2K | ﹤0.01% | 2585 |
|
|
2016
Q2 | $160K | Buy |
+1,955
| New | +$160K | ﹤0.01% | 2821 |
|